Other coronary interventions

800 results

PCI for in-stent restenosis complicated by neoatherosclerosis dissection

30 Apr 2024

Did you know that neoatherosclerosis (in the context of in-stent restenosis (ISR)) can suffer dissection, just like any native coronary artery, when balloon dilatation is performed?

Author

Lorenzo Azzalini

Coronary artery rupture in hybrid treatment

12 Apr 2024

Find out more about the step-by-step approach to effectively manage coronary artery rupture using prolonged balloon inflation.

Author

Paul Gamboa

One-month ticagrelor monotherapy after PCI in acute coronary syndromes: Principal results from the double-blind, placebo-controlled Ultimate DAPT trial

07 Apr 2024

Elad Asher provides his take on the ULTIMATE-DAPT Trial results which Gregg W Stone presented at ACC.24 in Atlanta.

Author

Elad Asher

Coronary vasomotor dysfunction is associated with cardiovascular events in patients with nonobstructive coronary artery disease

29 Mar 2024

In this large single centre registry investigators demonstrated that with the exception of endothelium independent epicardial coronary artery dysfunction, CVDys diagnosed by interventional functional assessment is correlated with adverse cardiac and cerebrovascular events.

Reviewer

Leonidas Koliastasis

Reviewer

Nicola Ryan

Double trouble: uncrossable calcified lesion complicated with iatrogenic ostial dissection

11 Apr 2024

How should this 74-year-old woman with HTN, DM, LVEF 45 %, inferior hypokinesia, and no valvular disorders be managed after presenting with a subacute inferior STEMI of less than 24 hours? Before uncovering the authors' approach, provide your analysis!

Author

Judit Andréka

Author

Günther Prenner

Author

Sascha Paetzold

Author

Gabor G. Toth

Preventive PCI or medical therapy alone for atherosclerotic coronary vulnerable plaques (PREVENT)

08 Apr 2024

Ali Nazmi Calik provides his take on the results of the PREVENT trial presented at ACC.24 in Atlanta.

Author

Ali Nazmi Calik

Coronary sinus reducer for the treatment of refractory angina: A randomised, placebo-controlled trial (ORBITA-COSMIC)

08 Apr 2024

Aaysha Cader interviews Rasha Al-Lamee and Michael Foley about the results of the ORBITA-COSMIC trial presented at ACC.24 in Atlanta.

Results showed that coronary sinus reducer relieved angina symptoms but lacked evidence of increased blood flow to the heart. While beneficial for refractory angina patients, its mechanism remains...

Author

Rasha Al-Lamee

Author

Aaysha Cader

Author

Michael Foley

Medically treated nonischemic thin-cap fibroatheroma lesions versus fractional flow reserve-guided complete revascularization in diabetic patients

27 Feb 2024

This sub-analysis denotes that medically treated diabetic patients with FFR-negative, TCFA-carrying target lesions were associated with a higher rate event rate compared to angiographically similar ischemic target lesions that underwent revascularization.

Reviewer

Mirvat Alasnag

Five most impactful trials in 2023

02 Jan 2024 – From GulfPCR-GIM 2023

Find out how, based on an initial clinical situation, the scientific evidence gathered between January and December on the key subjects selected for 2023, focusing on coronary issues, might have had an impact on daily practice, or is encouraging changes in practice, from MVD in ACS...

It’s (never) just a quick, diagnostic cath…

02 Jan 2024

Step-by-step video on how to successfully manage a universal radial diagnostic catheter induced coronary dissection.

Author

Bilal Aijaz